Percent change in wound area of diabetic foot ulcers over a 4-week period is a robust predictor of complete healing in a 12-week prospective trial

Plastic and Reconstructive Surgery

Volumn 117, Issue 7 SUPPL., 2006, Pages

  Sheehan, Peter ^a   Jones, Peter ^b   Giurini, John M ^c   Caselli, Antonella ^c   Veves, Aristidis ^c,d  

^a NYU HOSPITAL FOR JOINT DISEASES   (United States)

^b With Confidence Ltd   (United Kingdom)

^c HARVARD MEDICAL SCHOOL   (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; OXIDIZED REGENERATED CELLULOSE;

ADULT; AGED; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIABETIC FOOT; FEMALE; GAUZE DRESSING; HEALING; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TREATMENT DURATION; TREATMENT OUTCOME; WOUND ASSESSMENT; WOUND CARE; WOUND DRESSING; WOUND HEALING; WOUND HEALING IMPAIRMENT;

EID: 33748272307     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.prs.0000222891.74489.33     Document Type: Article

References (22)

1. Most, R. S., Sinnock, P. The epidemiology of lower extremity amputations in diabetic individuals. Diabetes Care 6: 87-91, 1983.
2. Smith, D. M., Weinberger, M., Katz, B. P. Predicting nonelective hospitalization: a model based on risk factors associated with diabetes mellitus. J Gen Intern Med 2: 168-173, 1987.
3. Ramsey, S. D., Newton, K., Blough, D., McCullogh, D. K., Sandhu, N., Reiber, G. E., Wagner, E. H. Incidence, outcomes and cost of foot ulcers in patients with diabetes. Diabetes Care 22: 382-387, 1999.
4. Reiber, G. E. Epidemiology and health care costs of diabetic foot problems. In The Diabetic Foot. Veves A, Giurini JM, LoGerfo FW, Eds. Totowa, NJ, Humana Press, p. 35-58, 2002.
5. Sedory Holzer, S. E., Camerota, A., Martens, L., Cuerdon, T., Crystal-Peters, J., Zagari, M. Costs and duration of care for lower extremity ulcers in patients with diabetes. Clin Ther 20: 169-181, 1998.
6. Glover, J. L., Weingarten, M. A., Buchbinder, D. S., Poucher, R. L., Deitrick, G. A. 3rd, Fylling, C. P. A 4-year outcome based retrospective study of wound healing and limb salvage in patients with chronic wounds. Adv Wound Care 10: 33-38, 1997.
7. Ragnarson-Tenmvall, G., Apelqvist, J. Cost effective management of diabetic foot ulcers. PharmacoEconomics 12: 42-53, 1997.
8. Apelqvist, J., Ragnarson-Tenmvall, G., Persson, U., Larsson, J. Diabetic foot ulcers in a multidisciplinary setting: an economic analysis of primary healing and healing with amputation. J Intern Med 235: 463-471, 1994.
9. Basile, P., Rosenbloom, B. Local care of the diabetic foot. In The Diabetic Foot. Veves A, Giurini JM, LoGerfo FW, Eds. Totowa, NJ, Humana Press, p. 279-292, 2002.
10. Veves, A., Sheehan, P., Pham, H. T. A randomized, controlled trial of Promogran (a collagen/oxidized regenerated cellulose dressing) vs standard treatment in the management of diabetic foot ulcers. Arch Surg 137: 822-827, 2002.
11. Wieman, T. J., Smiell, J. M., Su, Y. Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers: a phase III randomized placebo-controlled double-blind study. Diabetes Care 21: 822-827, 1998.
12. Veves, A., Falanga, V., Armstrong, D. G., Sabolinski, M. L. The Apligraf Diabetic Foot Ulcer Study: Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multi- center clinical trial. Diabetes Care 24: 290-295, 2001.
13. Naughton, G., Mansbridge, J., Gentzkow, G. A metabolically active human dermal replacement for the treatment of diabetic foot ulcers. Artif Organs 21: 1203-1210, 1997.
14. American Diabetes Association: Consensus Development Conference on Diabetic Foot Wound Care. Diabetes Care 22: 1354-1360, 1999.
15. Margolis, D. J., Kantor, J., Santanna, J., Strom, B. L., Berlin, J. A. Risk factors for delayed healing of neuropathic diabetic foot ulcers: a pooled analysis. Arch Dermatol 136: 1531-1535, 2000.
16. Robson, M. C., Hill, D. P., Woodske, M. E., Steed, D. L. Wound healing trajectories as predictors of effectiveness of therapeutic agents. Arch Surg 135: 773-777, 2000.
17. van Rijswijk, L., Polansky, M. Predictors of time to healing deep pressure ulcers. Ostomy Wound Management 40: 40-48, 1994.
18. Tallman, P., Muscare, E., Carson, P., Eaglstein, W. H., Falanga, V. Initial rate of healing predicts complete healing of venous ulcers. Arch Dermatol 133: 1231-1234, 1997.
19. Margolis, D., Kantor, J., Margolis, D. J. A multicentre study of percentage change in venous leg ulcer area as a prognostic index of healing at 24 weeks. Br J Dermatol 142: 960-964, 2000.
20. Van Rijswijk, L. Full-thickness leg ulcers: patient demographics and predictors of healing: Multi-Center Leg Ulcer Study Group. J Fam Pract 36: 625-632, 1993.
21. Phillips, T. J., Machado, F., Trout, R., Porter, J., Olin, J., Falanga, V. Prognostic indicators in venous ulcers. J Am Acad Dermatol 43: 627-630, 2000.
22. Pham, H. T., Sabolinsky, M. L., Veves, A. Healing rate measurement can predict complete wound healing rate in chronic diabetic foot ulceration (Abstract). Diabetes 49 (Suppl. 1): A197, 2000.